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Sulfation is an important molecular modification which regulates essential cellular processes 
and is also implicated in numerous pathological processes. The enzymes responsible for this 
reaction in living organisms are sulfotransferases. The gene Hoch_5094 from Haliangium 
ochraceum is annotated as a putative sulfotransferase. The protein codified by this gene —
HocAST— was heterologous expressed in E. coli and showed arylsulfotransferase activity. CD 
analysis of HocAST showed a main α/β secondary structure that agrees with the overall 
structure of other cytosolic sulfotransferases. Interestingly, HocAST was able to use both p-NPS 
and PAPS as sulfuryl donors in a contrary manner to what happens with the arylsulfate 
sulfotransferase (ASST) that cannot use PAPS as donor. Regarding the specificity towards the 
acceptor, HocAST has shown quite a wide scope and was able to accept several mono- and 
dihydroxylated phenols and other phosphorylated compounds as substrates. 
 
Introduction 
Sulfation is an important molecular modification in all living organism which regulates essential 
cellular processes and is also implicated in numerous pathological processes.[1] The enzymes 
responsible for this reaction in living organisms are sulfotransferases (EC 2.8.2.-). These 
enzymes catalyze the transfer of a sulfuryl moiety (SO3-) from the 3’-phosphoadenosine-5’-
phosphosulfate (PAPS), to the hydroxyls and primary amines of a variety of acceptors. In 
eukaryotes two classes of sulfotransferases have been described: Golgi-membrane 
sulfotransferases (ST’s) that sulfate larger molecules such as polysaccharides and proteins, and 
cytosolic sulfotransferases (SULT’s) that transfer the sulfuryl group from PAPS to phenols, 
steroids, hormones, amines, and xenobiotics. This latter family is also known as phenol or aryl 
sulfotransferases (ArylST).[2] Besides these two families, a group of PAPS-independent 
sulfotransferases that use two aryl substrates, one as sulfuryl donor and the other one as 
acceptor, have been described in bacteria. Although the bacterial arylsulfate sulfotransferase 
(ASST) was first described in commensal intestinal bacteria as early as 1986, the identity of the 
natural donor has not been clearly established.[3]  
From a synthetic point of view, STs are quite attractive because of their ability to sulphate, in a 
regio- and stereoselective manner, complex polysaccharides such as glycosaminoglycans 
(GAGs) that are polymers that play crucial roles in development and organogenesis and thus 
seem to be essential for multicellular life.[4] However, the synthetic use of ST is hampered due 
to the high cost and instability of PAPS and the problem of product inhibition caused by 3’-
phosphoadenosine-5’-phosphate (PAP).[5] Besides their use for the sulfation of different 
flavonoids, steroids, peptides and aliphatic alcohols,[6] ArylST, in particular rat liver aryl 
sulfotransferase IV (Ast IV), has been used to develop a one-enzyme regeneration system for 
PAPS (Scheme 1).[7] This cycle is based in the reversibility of the reaction catalyzed by the 
ArylST.[8] Thus, when coupled to another PAPS-dependent sulfotransferase, the ArylST can 
transfer the sulfuryl group from p-nitrophenyl sulfate (p-NPS) to PAP regenerating PAPS in situ 
and overcoming the inhibition by PAP. On the other hand, scale-up of this regeneration system 
is hampered due to the poor stability of the pure Ast IV.[6c] Therefore, search for new ArylST 
with better properties as biocatalyst is still needed. In this sense, the gene Hoch_5094 from 
the bacteria Haliangium ochraceum codifies for a putative aryl sulfotransferase. Herein, we 
describe the heterologous expression of the gene Hoch_5094 in Escherichia coli and the 
biochemical characterization of the gene product as well as a preliminary analysis of its donor 
and acceptor specificity. 
 
Results and Discussion 
Sequence analysis of the aryl sulfotransferase from Haliangium ochraceum 
In recent years the number of complete genomes, especially from bacteria which have been 
sequenced, has grown dramatically, providing a unique source for finding new enzymes. 
Haliangium ochraceum is the type species of the genus Haliangium in the myxococcal family 
Haliangiaceae and its genome has been sequenced recently.[9] The product of the gene 
Hoch_5094 is annotated as a putative sulfotransferase due to the sequence homology with the 
family SULT_1 (Pfam00685).[10] Since there is no experimental evidence of the activity of this 
enzyme we decided to make a comparative analysis of its sequence with the well characterized 
SULT from human (HsSULT1A1a), rat (RnSULT1A1) and mouse (MmSULT1D1). The domains 
that define the phenol sulfotransferase activity[11] are shown in figure 1:  
Box A. This domain is known as the Phosphosulfurile Binding Site (PBS) and interacts with the 
5’-phosphate from PAPS pointing the sulfuryl donor to the acceptor in the active site. 
Box B. This highly conserved region includes the catalytic histidine (H105 in HocAST). It is 
expected that the amino acids in this domain contribute significantly to the structure of the 
active center. 
Box C. In HsSULT1A1a R130 and S138 interact with the 3’-phosphate group of PAPS. In 
addition, S138 avoids the hydrolysis of PAPS in the absence of acceptor substrate. 
Box D. This domain contains the motive GxxGxWK, highly conserved in this kind of 
sulfotransferases. This sequence interacts with the 3’-phosphate of PAPS and, together with 
domain C, stabilizes its binding to the active site. In HocAST there is an R instead of the K but 
since both amino acids are basic and have similar properties, it can be expected that the role 
of this domain is conserved in this enzyme. 
We performed an automated protein structure homology modeling in the Swiss-Model[12] 
server using the protein SULT1D1 from M. musculus (PDB entry 2zyt as template).[13] The fold 
of HocAST is highly conserved when superposed to other sulfotransferases for which 
structures have been already solved. The topology of HocAST fold was 1, 1, 2, 3, 2   
4, 4, 5, 5, 6, 6, 7, 8, 9, 10, 11, 12, which was virtually identical to the topology of 
the SULT proteins (Figure 2A). In order to confirm that the catalytic residue of the HocAST 
could be the Hist105 (deduced by alignment) we carried out docking studies of the model 
protein with PAP and p-NPS obtaining a glide score of -8.59 kcal/mol (Figure 2B).[14] In the 
HocAST-PAP complex, the 5’-phosphate group of PAP is positioned in an analogous manner as 
does the phosphate group of PAPS in the crystallographic MmSULT1D1-PAPS complex (see SI, 
Figure 1S). In both cases the phosphate groups are at 3 Å from the catalytic Hist (residue 105 in 
HocAST and 108 in MmSULT1D1).  
Therefore, since HocAST presented the main structural characteristics and an overall 3D 
structure in agreement with the cytosolic sulfotransferases, we decided to carry out its 
expression in E. coli to perform a detailed structural and functional analysis as well as to 
explore its synthetic applicability. 
Expression and structural characterization of HocAST 
The gene Hoch_5094 was amplified by PCR from the genomic DNA of Haliangium ochraceum 
using primers designed to complement specifically 25 bp at the 5’ end of the codifying and 
complementary DNA strains. The recognition sequence for the restriction enzymes NdeI and 
XhoI were introduced in the amplification product during PCR. The resulting amplified band 
had the expected size (954 bp) and was digested and introduced in the expression vector pET-
28b(+) which introduces a 6 histidines tag in the N-terminal of the recombinant protein. 
E. coli BL21 (DE3) cells were transformed with this plasmid and the expression of recombinant 
protein was induced with 0.5 mM IPTG at OD600nm 0.5-0.6. SDS-PAGE analysis of HocAST 
expression showed a band of the expected molecular mass (37 kDa) in the soluble fraction that 
represented 70% of the total protein. HocAST was purified by immobilized metal affinity 
chromatography (IMAC) through the His-tag. 
Purified recombinant protein presented a mass of 37221 Da and the peptide mass fingerprint 
showed 18 peptides that cover the sequence of HocAST and identifies it unequivocally (Figure 
3). The quaternary structure of the enzyme was analysed by size-exclusion chromatography. 
The recombinant protein in the chromatographic column was eluted in two peaks at 100 and 
150 mL (see SI, Figure 2S). Peak 1 corresponds to the exclusion volume which contains 
oligomers of the protein. When the elution volume of peak 2 was interpolated into the 
calibration curve, weight of about 40 kDa corresponding to the monomer of HocAST was 
obtained (see SI, Figure 2S). 
The spectroscopic characterization of purified HocAST is shown in Figure 4. The far-UV CD 
spectrum shows 2 minima in ellipticity at ∼210 and ∼220 nm, indicative of a main α/  
secondary structure (Figure 4a). The tertiary structure of the protein in the environment of the 
fluorophores was analyzed by fluorescence emission spectroscopy of the 12 tryptophans and 
12 tyrosines contained in the sequence of HocAST (Figure 4b). Upon excitation at 275 nm, the 
spectrum exhibited an emission maximum centered at 335 nm, shifted about 15 nm from the 
position of the maximum described for free tryptophan in aqueous solution (348–350 nm).[15] 
This indicates that the average microenvironment of the tryptophans in HocAST is significantly 
more hydrophobic than that of a residue completely exposed to the solvent. This blue-shift of 
the fluorescence, together with the circular dichroism spectrum, supports the idea that the 
protein is expressed properly folded. Moreover, emission spectra obtained upon excitation at 
275 and 295 nm are practically identical, indicating an almost negligible contribution of 
tyrosines to the fluorescence spectrum of the protein. This contribution, lower than expected 
for a Trp:Tyr ratio of 12:12 is probably due to extensive resonance energy transfer from 
tyrosine fluorescence to nearby tryptophans and/or to quenching by other close side chains. 
Biochemical characterization of HocAST 
The time course of the reaction catalysed by the recombinant HocAST was followed in the 
sense of PAPS formation by monitoring the increase in absorbance at 405 nm due to the 
appearance of p-NP (1). The increase in absorbance was linear with enzyme concentration and 
reaction time. These results clearly indicated that HocAST was able to transfer the sulfuryl 
group from p-NPS to PAP (2) showing aryl sulfotransferase activity. The initial rate of the 
reaction measured over a range of substrate concentrations showed a Michaelis-Menten 
behavior (see SI, Figure 3S). Apparent kinetic parameters of HocAST enzyme were calculated 
independently for both substrates p-NPS and PAP (Table 1). It is difficult to compare these data 
with others reported in the literature since they are apparent parameters and then dependent 
on the conditions under which the assay was carried out. Nevertheless, they are of the same 
order as those reported for the sulfotransferase STF9 from Mycobacterium avium, another 
sulfotransferase which is also able to use PAPS and p-NPS as sulfuryl group donors.[16]  
The recombinant HocAST exhibited activity between pH 6.0 and 7.5, with the maximum 
activity at pH 6.5. At pH’s over 7.5 the activity drops drastically to virtually zero (see SI, Figure 
4S). To study the thermal stability of the HocAST, the enzyme was incubated at 4, 25, 37 and 
45 ºC over time and their remnant activities were evaluated at room temperature (Figure 5). 
We therefore determined in this assay the progressive loss of activity due to irreversible 
denaturation of the enzyme. The melting temperature of the recombinant HocAST was 
determined by thermal shift experiment as 33 ºC (see Experimental section and Figure S5). 
Accordingly with this data, we observed a significant decreased of the half-life of the enzyme 
between 25 and 37 ºC (Figure 5). At 25 ºC the half-life of the sulfotransferase was over 3 h, but 
at 37 ºC it was only 36-37 min and at 45 ºC less than 6 min (Figure 5). On the other hand, at 4 
ºC the enzyme kept over 90 % of activity for days. 
Substrate specificity studies 
For this preliminary study of the HocAST substrate specificity, we assayed different 
commercially available phenolic compounds, aliphatic alcohols and biologically relevant 
phosphorylated compounds that can be considered PAP analogous (Scheme 2). 
A preliminary screening was carried out using a thermal shift assay.[17] The assay involves 
monitoring changes in the fluorescence signal of SYPRO orange dye as it interacts with the 
hydrophobic core of a protein undergoing thermal unfolding. The Tm value of the protein will 
increase in the presence of ligands that bind to the properly folded protein. In those cases 
where an increase of the Tm (ΔTm) was detected, we carried out the sulfation reaction as 
described in the Experimental Section and the formation of the reaction product was 
confirmed by electrospray mass spectrometry (ESI-MS). The results are summarized in Table 2. 
HocAST is able to transfer the sulfuryl group from p-NPS to the hydroxyl group of phenolic 
compounds with relatively good activity but aliphatic alcohols were not substrates of the 
enzyme. The best substrate was 4,4’-Biphenol (11) probably due to the symmetry of the 
molecule. In the case of catechol (4) we could detect not only the monosulfated product but 
the disulfated one as well ([M+2]+ 191.2 and [M+1]+ 269.8 respectively). The assayed 
nucleoside triphosphates were good acceptors for the enzyme and the obtained results 
indicate that the nucleoside moiety is needed to be recognized by the enzyme since 
triphosphate was neither ligand nor substrate. Finally, we assayed the capacity of HocAST to 
transfer the sulfuryl group from PAPS to three different nitrophenols (1, 8 and 9). The activity 
with p-NP (1) was about half of the activity shown with p-NPS and PAP. With o-NP (8) the 
activity was quite similar but strongly decreased with dinitrophenol 9 with which showed a 
residual activity (about 2% of the activity showed with p-NPS). 
 
Conclusion 
In conclusion, we have shown experimentally that the gene Hoch_5094 from Haliangium 
ochraceum encodes for an arylsulfotransferase. CD analysis of HocAST showed a main α/  
secondary structure that agrees with the overall structure of other cytosolic sulfotransferases. 
HocAST is a very versatile enzyme since it is capable of use both p-NPS and PAPS as sulfuryl 
donors. Regarding the specificity towards the acceptor, HocAST has shown a broad scope, 
being able to accept as substrates different phenolic compounds and nucleoside triphosphate 
as substrates. Therefore, HocAST is an interesting addition to the biocatalysts toolbox for 
enzymatic sulfation of compounds biologically relevant. 
 
Experimental Section 
Materials and General Procedures 
E. coli BL21(DE3) competent cells were purchased from Stratagene Co. (San Diego, CA). 
Restriction enzymes, Taq polymerase and T4-DNA ligase were purchased from MBI Fermentas 
AB (Lithuania). PCR primers were purchased from Isogen Life Science (Spain) and the pET-
28b(+) expression vector was purchased from Novagen. Isopropyl--D-thiogalactopyranoside 
(IPTG) was purchased from Applichem GmBH (Germany). Plasmids and PCR purification kits 
were from Promega (Madison, WI) and DNA purification kit from agarose gels was from 
Eppendorf (Hamburg, Germany). SDS-PAGE was performed using 10% and 5% acrylamide in 
the resolving and stacking gels, respectively. Gels were stained with Coomassie brilliant blue R-
250 (Applichem GmBH, Germany). Electrophoresis was always run under reducing conditions, 
in the presence of 5% β-mercaptoethanol. Nickel-iminodiacetic acid (Ni2+-IDA) agarose was 
supplied by Agarose Bead Technologies (Spain). All compounds were purchased from Sigma–
Aldrich and were used directly. Solvents were of analytical grade. DNA manipulation was 
according to standard procedures.[18]  
Expression and purification of the arylsulfotransferase from Haliangium ochraceum 
Hoch_5094 gene was amplified by PCR on a iCycler Thermal Cycler (MiniOpticon, BioRad) using 
as template genomic DNA from Haliangium ochraceum obtained from DSMZ (German 
Collection of Microorganisms and Cell cultures, DSM nº 14365). Forward primer was 
5’TATAACATATGAATTCTACTGACGAACAACACA3’ (NdeI restriction site underlined) and the 
reverse primer was 5’CTCGAGTCAGTCCGGCAGCTCGCCG3’ (XhoI restriction site underlined). 
PCR amplification was performed in 5µL reaction mixture containing DMSO 20% and subjected 
to 29 cycles of amplification. The cycle conditions were set as follows: denaturation at 94 ºC 
for 1 min, annealing at 50 ºC for 2 min and elongation at 72 ºC for 2 min. After digestion, the 
purified PCR product was ligated in the pET-28b(+) vector double digested with the same 
restriction enzymes.  
For the expression of the Hoch_5094 gene, transformed E. coli BL21 (DE3) cells, carried on the 
pET-AST6xHis plasmid, were grown in LB medium supplemented with kanamycin (26 μg∙mL-1) 
at 37 ºC. When the culture reached an OD600 of 0.5-0.6, protein expression was induced with 
isopropyl β-d-1-thiogalactopyranoside (IPTG, 0.4 mM) and the temperature was lowered to 30 
ºC. After 18 hours, cells were harvested by centrifugation (3800 x g) for 30 min at 4 ºC. Cell 
pellets were re-suspended in monosodium phosphate buffer (25 mM; pH 7.4) and treated with 
lysozyme and DNase for protein extraction.[19] The solution was centrifuged for 40 min 
(8000 × g, 4 ºC) and collected for purification. The supernatant, containing the recombinant 
protein, was loaded onto a Ni+2-IDA-agarose column pre-equilibrated with sodium phosphate 
buffer (20 mM, pH 7.5). The recombinant ArylST was eluted with the same buffer containing 
imidazole 500 mM. All the fractions containing protein were pooled together and dialyzed to 
remove the imidazole. Sodium dodecylsulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) 
showed a single band matching the expected molecular weight of the recombinant ArylST (37 
kDa). 
Sequence analysis and 3D modelization of the HochAST 
To analyze the sequence of HocAST an alignment of 4 sequences was performed using 
ClustalX.[20] The modelization of HochAST was made in the SwissModel server with the best 
template option.  
Protein analysis 
Peptide-mass fingerprint analysis from the SDS-PAGE band corresponding to the hypothetical 
HocAST was performed at the Proteomic Unit of the Spanish National Center of Biotechnology 
(CNB-CSIC). Samples were digested with sequencing grade trypsin O/N at 37 ºC. The analysis 
by MALDI-TOF mass spectrometry produces peptide mass fingerprints and the peptides 
observed can be collated and represented as a list of monoisotopic molecular weights. Data 
were collected in the m/z range of 800-3600. 
Quaternary structure of HocAST was determined by size-exclusion chromatography with no-
denaturing conditions. To this extent, the protein was loaded into a HiLoad 26/60 SuperdexTM 
75 PG column, controlled by the AKTA-FPLC system (GE-Healthcare Life Science). The column 
was developed in phosphate buffer (50 mM, pH 7.2) containing NaCl (0.15 M) at a constant 
flow rate of 1.0 mL∙min-1. A calibration curve was made with the retention times of well-known 
proteins with molecular weight (MW) between 15 kDa and 70 kDa. 
Circular dichroism (CD) and fluorescence spectroscopy 
Far-UV circular dichroism (CD) spectra were recorded in the wavelength range of 195-250 nm 
using a Jasco J-815 spectropolarimeter equipped with a constant temperature cell holder Jasco 
PTC423-S Peltier. The protein concentration was 14 M. The optical p      
The contribution of the buffer was always subtracted. For each sample, four spectra were 
accumulated at a scan speed of 20 nm/min with a bandwidth of 0.2 nm and averaged 
automatically. The mean residue ellipticity, [ ], is given in units of deg∙cm2∙dmol-1. A value of 
110 g/mol was used as mean weight for residue.  
Tryptophan fluorescence emission spectra of HocAST were recorded in a Jasco FP-8300 
spectrofluorimeter and data were treated with the SpectraManager program. The contribution 
of the buffer was always subtracted. A quartz cell with a 1 cm path length in both the 
excitation (275 nm and 295 nm) and emission (295 to 400 nm) directions was used in all the 
experiments. The HocAST protein concentration was 10 M in phosphate    
pH=7.5) and experiments were carried out at 25 ºC. 
Enzyme activity assays and steady-state kinetic analysis 
HocAST activity measurement was carried out using a high throughput colorimetric 96-well 
plate assay. Sulfotransferase activity assays were run at room temperature following the 
increase of absorbance at 405 nm ( p-NP = 18000 M-1 cm-1) for 15 min. In a total volume of 250 
L of reaction mixture HEPES buffer (50 mM, pH 7.0), p-NPS (between 0 and 0.5 mM as 
indicated) and acceptor (between 0-0.02 mM as indicated) were added. The reactions were 
initiated upon addition of 50 μl of HocAST (14 M). In all cases      
addition of 50 L of NaOH 1N. Fo          
only one substrate), initial velocities (V0) were fitted to the Michaelis-Menten equation. 
Kinetics parameters were calculated using the built-in nonlinear regression tools in SigmaPlot 
11.0 
Substrate specificity studies 
Thermal shift assays were carried out in a iQ5 Real Time Detection System (Bio-Rad,CA). To 
monitor the protein unfolding, the fluorescent dye Sypro orange was used. The dye’s 
fluorescence signal is quenched in the aqueous environment of a properly folded protein in 
solution, but as the protein unfolds, it exposed its hydrophobic residues to the environment. 
The dye then binds to the hydrofobic regions and becomes unquenched. 5 L of acceptor 
solutions (10 mM) were added to 45 L of Tris buffer        
Sypro Orange and 4.4 M of protein. Th               
0.2 ºC∙min-1. The fluorescence intensity was measure with Ex/Em 490/530. 
In those cases where a thermal shift was detected, sulfotransferase activity was confirmed by 
the colorimetric method described above. On the other hand, to determinate the activity of 
the HocAST using PAPS as sulfuryl donor, reaction mixtures contained 184 μl of phosphate 
buffer (50 mM, pH 7.0), 2.7 L of PAPS (9 mM) and 7.5 l o     The reactions 
were initiated upon addition of 50 μl of HocAST (14 M). 
In all cases, the identity of the reaction products was confirmed by Positive-ion ESI-MS 
spectrometry: m/z: 3’-phosphoadenosine-5’-phosphosulfate (PAPS) 506.9 [M+]; Adenosine-5'-
triphosfate 5’-sulphate (ATPS) 587 [M+]; Guanosine-5'-triphosphate-5’-sulphate (GTPS) 603 
[M+]; Citidine-5’-triphosphate-5’-sulphate (CTPS) 563.9 [M+]; Uridina-5'-triphosphate-5’-
sulphate (UTPS) 564.7 [M+]; phenol sulfate 174.2 [M+]; 4,4’-biphenol sulfate, 266.0 [M+]; 
Cathecol monosulphate 191.2 [M2+]; cathecol disulfate 269.8 [M]; p-Nitrophenolsulphate 
245.0 [NaM+]; 2,4-Dinitrophenolsulphate 280.6 [NaM+] 
Molecular docking studies 
Crystal structure of the complex between human sulfotransferase SULT1A1 and PAP and from 
the mutant D249G with PAP and p-NP, were obtained from the PDB (entries 3u3j and 3u3r 
respectively). The receptor was prepared using the Wizard tool of the Schrödinger suit. The 
initial conformation of PAP and p-NP were taken from the crystal structures. Subsequently, 
they were prepared using LigPrep by modifying the torsions of the ligands and assigning its 
appropriate protonation states. In Glide, 32 stereochemical structures were generated per 
compound with possible states at target pH 7.0 ± 2.0 using Ionizer, tautomerized, desalted and 
optimized by producing low-energy 3D structure for the ligand under the OPLS 2005 force 
field[22] while retaining the specified chiralities of the input Maestro file. Then, receptor grid 
was calculated for the prepared receptor such that various ligand poses bind within the 
predicted site during docking. In Glide, grids were generated keeping the default parameters 
of van der Waals scaling factor 1.00 and charge cutoff 0.25 subjected to OPLS 2001 force field. 
A cubic box of specific dimensions (15 Å x 15 Å x 15 Å) center on the donor or acceptor was 
generated for the protein. After that, SP flexible ligand docking was carried out in Glide of 
Schrödinger-Maestro v9.2.7. Final scoring was performed on energy-minimized poses and 
displayed as Glide score. The best docked pose was recorded for the ligand. 
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Tables 
Table 1. Apparent kinetic parameters of HocAST for p-NPS and PAP.[a]  
Substrate KM (µM) Vmax (µmol/min/mg) Vmax/ KM  
p-NPS 45.9 ±2.2 0.84 ±0.008 0.018 
PAP 4.0 ±0.9 0.76 ±0.015 0.19 
[a] Kinetic parameters calculated at 25 ºC and pH 7.0 
 
Table 2. Screening of HocAST acceptor specificity. 
Compound ΔTm (ºC) Activity (%)[a] 
3 2.0 12.0 
4 0.8 18.0 
5 —[b] N/A[c] 
6 —[b] N/A[c] 
7 —[b] N/A[c] 
10 —[b] N/A[c] 
11 2.0 93.0 
12 —[b] N/A[c] 
13 —[b] N/A[c] 
14 1.4 4.4 
15 2.8 17.0 
16 1.0 4.4 
17 2.4 9.7 
18 —[b] N/A[c] 
19 —[b] N/A[c] 
[a] 100 % of activity is the maximum reaction rate 
with PAP as acceptor and p-NPS as sulfuryl donor. 
[b] No increase of the Tm was detected. [c] N/A = 
Not applicable. 
 
  
Figure legends 
Scheme 1. PAPS regeneration cycle based in the use of aryl sulfotransferases. 
Figure 1. Alignment of the amino acid sequence of the hypothetical aryl sulfotransferase from 
Haliangium ochraceum versus three known sulfotransferases. The boxes (A, B, C and D) frame 
the conserved regions involved in the aryl sulfotransferase activity. 
Figure 2. (A) Modelling of the tertiary structure of the protein HocAST; the reactive His105 is 
show in sticks and the conserved motifs in colours: Box A, density blue; Box B, cyan; Box C, 
deep blue and Box D, light blue; (B) Docking of p-NPS and PAP in the HocAST modelling. For 
details see text. 
Figure 3. Peptide mass fingerprint of HocAST. The sequence of the identified peptides is 
shaded and underlined. The molecular mass of each peptide is indicated in Da. 
Figure 4. Spectroscopic characterization of recombinant HocAST. (a) Far-UV circular dichroism 
spectrum. (b) Tryptophan fluorescence emission spectrum; the fluorescence intensity (FI) is 
presented in arbitrary units (au). 
Figure 5. Thermal stability of the recombinant HocAST at 4 ºC (), 25 ºC (), 37 ºC () and 45 
ºC (). 
Scheme 2. Structure of the compounds assayed in this study as possible substrates of HocAST. 
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Figure S1. Crystallographic MmSULT1D1-PAPS complex (PDB entry 2zyt).1 PAPS and His108 
are shown in sticks. 
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Figure S2. A) FPLC chromatogram of HocAST shows two main peaks with at elution volume of 
110 mL (1) and 150 mL (2). B) Calibration curve prepared with proteins of known mass. C) SDS-
PAGE of peaks 1 and 2.  
 
 
 
 
 
 
Figure S3. Substrate kinetics for HocAST at 25ºC and pH 7.0. (A) p-NPS concentration 0-500 µM 
with a fix concentration of PAP (20 µM); (B) PAP concentration 0-20 µM with a fix concentration 
of p-NPS (1.0 mM). In all cases reactions were stopped with NaOH 1N. 
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Figure S4. HocAST pH-activity profile. 
 
 
 
 
 
Figure S5. Thermal shift experiment of HocAST alone and with some ligands. In the case of the 
enzyme without any ligands a minimum at 33 ºC can be observed. This value corresponds to the 
melting temperature of the recombinant enzyme. 
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